We are party to an exclusive license agreement with Columbia University under which we are granted rights to intellectual property that are necessary to our business
Reciprocal relationship from ORANY graph: Reciprocal relationship from BLTE graph: rting, reporting of certain deviations and adverse experiences, providing the regulatory authorities with updated sa…
rting, reporting of certain deviations and adverse experiences, providing the regulatory authorities with updated safety and efficacy information, drug sampling and distribution requirements, and com…
Reciprocal relationship from ORANY graph: Reciprocal relationship from BLTE graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from BLTE graph: Reciprocal relationship from ORAN…
rting, reporting of certain deviations and adverse experiences, providing the regulatory authorities with updated safety and efficacy information, drug sampling and distribution requirements, and com…
Belite Bio, Inc Debt Obligations
Instrument
Description
Confidence
Evidence
BLTE-DEBT-8265
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
BLTE-DEBT-8264
Warrants outstanding: 102993000
90%
xbrl warrant detail from xbrl 2025-12-31.
BLTE-DEBT
Debt stack $429,000
90%
Market cache reports total debt of $429,000.
Belite Bio, Inc Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Belite Bio, Inc.
Belite Bio, Inc Ownership
Holder
Name
Confidence
Evidence
BLTE-OWNER-DARWIN-GLOBAL-MANAGEMENT-LTD
Darwin Global Management, Ltd.
90%
13F overlay lists Darwin Global Management, Ltd. as top holder; 77 tracked holders.